Drug
Thymalfasin clinical trials
Also written Zadaxin.
- studies test it
- 43
- open now
- 14
- in phase 3
- 5
- first study started
- 2002
Keep track of what changes. Save the Thymalfasin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Zadaxin
- 11
Studies by the year they started
41 studies that test it; most in 2016 (5); 1 more planned to start later
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 22
- Phase 3
- 5
- Phase 4
- 8
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 36
Sun Yat-sen University (7) · Beijing Friendship Hospital (4) · sigma-tau i.f.r. S.p.A. (3) · SciClone Pharmaceuticals (3) · Zhejiang Provincial People's Hospital (3) · Fudan University (2) · Nanjing Medical University (2) · William B. Ershler, MD (1)
Often tested with
Tested in the same studies.
Peginterferon alfa-2a (2) · Concurrent Chemotherapy (1) · REP 2139 (1) · Dacarbazine (1) · Interferon Alpha (1) · Adebrelimab (1) · Antineoplastic Agents (1) · Urinastatin (1)
Studies
Open first, then newest update. How each study uses Thymalfasin is read from its arms, and is right about nine times in ten.
Testing it · 43
- Thymalfasin Combined With Chemotherapy and Immunotherapy in TNBC Neoadjuvant TreatmentNot yet recruitingPhase 2Fudan UniversityNCT07884201Written as Thymalfasin
- Thymosin-α1 for Recurrent Implantation FailureRecruitingPhase 2/3Fakih IVF Fertility CenterNCT07675980Written as Thymosin Alpha1
- Thymalfasin for Immune Recovery in Adults With SepsisRecruitingNot applicableShanghai Zhongshan HospitalNCT07866118Written as Thymalfasin (Thymosin alpha 1, Ta1)
- Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal CancerNot yet recruitingPhase 2The Affiliated Hospital of Putian UniversityNCT07780721Written as Thymalfasin
- Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 VaccineRecruitingPhase 1The Methodist Hospital Research InstituteNCT06821100Written as Thymalfasin (Thymosin alpha 1, Ta1)
- Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaRecruitingPhase 2Sun Yat-sen UniversityNCT07644897Written as Thymosin Alpha 1 and Anti-PD-1 monoclonal antibody
- Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingPhase 2Zekuan XuNCT06461910Written as thymalfasin
- AI-assisted Subtyping-directed Precision Treatment in Acute Aortic DissectionNot yet recruitingNot applicableNanjing Medical UniversityNCT07382375Written as Ulinastatin and Thymalfasin
- "Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"RecruitingPhase 2Beijing Friendship HospitalNCT06829355Written as Thymalfasin (Thymosin alpha 1, Ta1)
- Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLCNot yet recruitingNot applicableXuanwu Hospital, BeijingNCT06607926Written as Thymosin Alpha 1
- Immuno-effect of Tα1 for Stage I NSCLCRecruitingNot applicableYousheng MaoNCT06598839Written as Thymosin Alpha1
- Thymosin Alpha-1 for irAE Secondary to ICIsRecruitingPhase 4Jun WangNCT06178146Written as Thymosin Alpha1
- Thymalfasin-based PRaG Mode for Advanced Refractory Solid TumorsRecruitingPhase 2Second Affiliated Hospital of Soochow UniversityNCT05790447Written as Thymalfasin
- Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal CancerRecruitingPhase 3Fudan UniversityNCT05086614Written as Thymosin Alpha1
- The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLCCompletedPhase 2Sun Yat-sen UniversityNCT06139419Written as Thymosin Alpha1
- Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis PatientsCompletedPhase 2William B. Ershler, MDNCT04428008Written as Thymalfasin
- Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal CancerActive, not recruitingPhase 2Beijing Friendship HospitalNCT06056804Written as thymalfasin
- Abscopal Effect for Metastatic Colorectal CancerWithdrawnPhase 2Zhejiang Provincial People's HospitalNCT02535988Written as Thymalfasin
- Zadaxin and HIV-positive Patients With Immune Reconstitution DisorderCompletedEarly Phase 1Shanghai Public Health Clinical CenterNCT04963712Written as Zadaxin
- The Efficacy and Safety of Ta1 for SepsisCompletedPhase 3Sun Yat-sen UniversityNCT02867267Written as Thymosin alpha 1
See all 43 studies that test Thymalfasin →
Given in every arm · 4 — Thymalfasin is usual care beside what is tested
- Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical StaffStatus unknownPhase 3Shanghai Jiao Tong University School of MedicineNCT04320238Written as thymosin alpha 1
- Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced PatientsStatus unknownPhase 4Wen-hong ZhangNCT03448744Written as Thymosin Alpha1
- Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI TherapyStatus unknownPhase 2First People's Hospital of HangzhouNCT02787447Written as Thymosin Alpha 1
- Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild TypeStatus unknownPhase 2SciClone PharmaceuticalsNCT02906150Written as Thymalfasin (Thymosin alpha 1, Ta1)
Codes
What other systems call Thymalfasin · ClinicalTrials.gg INT006770
- MeSH (NLM) D000077596ThymalfasinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) W0B22ISQ1CTHYMALFASINConfirmed FDA, NLM
- RxNorm 38221One source FDA
- NCI Thesaurus C1253ThymalfasinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077596 | Thymalfasin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | W0B22ISQ1C | THYMALFASIN | Confirmed FDA, NLM |
| RxNorm | 38221 | — | One source FDA |
| NCI Thesaurus | C1253 | Thymalfasin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.